Michael Hellerstein

Michael Hellerstein is the Head of Operations at Vaxxinity, leading efforts in CMC development, regulatory affairs, program management, and quality assurance for a clinical-stage biotech company focused on neurodegenerative diseases. With extensive experience ranging from co-founding consulting firms like Hellerstein Consulting and Responsive BioServices to key regulatory roles at Kiel Laboratories and GeoVax Labs, Hellerstein has directed IND-enabling developments for multiple vaccine candidates and authored important regulatory submissions. Hellerstein's career began with foundational roles at Pfizer and Cell Signaling Technology after earning an AB in Biology from Harvard University.